Multi-Centre Phase IV Trial to Investigate the Immunogenicity of a New Liquid Formulation of Recombinant Human Growth Hormone in Adults With Growth Hormone Deficiency

Journal of Endocrinological Investigation - Switzerland
doi 10.1007/s40618-017-0818-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search